Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep17 | Adrenal and Cardiovascular Endocrinology | ECE2023

Adrenal lesions in patients with familial adenomatous polyposis

de Carlos Joaquin , Zabalza Lucia , Oquinena Susana , Irigaray Ana , Anda Emma

Introduction: Familial Adenomatous Polyposis (FAP) is an autosomal dominant disease classically characterized by the development of hundreds or thousands of adenomas in the rectum and colon during the second decade of life. Almost all patients will develop colorectal cancer (CRC) if not identified and treated at an early stage. It is a multisystem growth disorder so there is an increased risk of developing extraintestinal manifestations. In this context, an increase in adrenal...

ea0090ep318 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Atezolizumab induced new-onset type 1 diabetes mellitus and thyroiditis

de Carlos Joaquin , Zabalza Lucia , Garcia Torres Javier , Yoldi Jon , Esparza Nerea , Zubiria Juan

Introduction: Cancer is the result of genetic and epigenetic alterations generating uncontrolled cell growth. These molecular changes maintain an immunosuppressive microenvironment allowing tumor spread. Immune checkpoint inhibitors (ICI) are novel therapeutic strategies in cancer treatment, promoting anti-tumor response by boosting cytotoxic T lymphocytes. Despite their high effectiveness, they can trigger the activation of diverse autoimmune diseases in genetically predispos...

ea0090ep970 | Thyroid | ECE2023

Thyroid pathology in patients with familial adenomatous polyposis

de Carlos Joaquin , Zabalza Lucia , Rosario Aznarez Maria , Irigaray Ana , Anda Emma

Introduction: Familial Adenomatous Polyposis (FAP) syndrome is an autosomal dominant disorder associated with a high risk of multiple intestinal and extraintestinal cancers. They develop hundreds or thousands of adenomas in the rectum and colon during the second decade of life that. If they are not identified and treated, almost all patients develop colorectal cancer (CRC) and die by the age of 40-50 years. Thyroid carcinoma is a FAP manifestation with an unknown reported high...

ea0099ep137 | Thyroid | ECE2024

Thyroid pathology in patients with MUTYH syndrome

de Carlos Joaquin , Zabalza Lucia , Irigaray Ana , Rosario Aznarez Maria , Ernaga Ander , Anda Apinariz Emma

Introduction: MUTYH (MutY homolog Escherichia coli, homolog of MYH, hMYH) is a repair enzyme with a crucial role in the correction of DNA errors, being considered a protective factor of the cell. MUTYH mutations have been linked to MUTYH-associated polyposis syndrome (MAP), an autosomal recessive disorder characterized by multiple colorectal adenomas. Patients with MAP show a much higher lifetime risk of gastrointestinal cancers as an additional role of MUTYH, it appears to co...

ea0099ep405 | Adrenal and Cardiovascular Endocrinology | ECE2024

Adrenal lesions in in patients with MUTYH syndrome

de Carlos Joaquin , Zabalza Lucia , Irigaray Ana , Rosario Aznarez Maria , Yoldi Jon , Marti Miguel , Ayarza-Marien Xabier , Anda Apinariz Emma

Introduction: MUTYH (MutY homolog Escherichia coli, homolog of MYH, hMYH) is a repair enzyme with a crucial role in the correction of DNA errors, being considered a protective factor of the cell. MUTYH mutations have been linked to MUTYH-associated polyposis syndrome (MAP), an autosomal recessive disorder characterized by multiple colorectal adenomas. Patients with MAP show a much higher lifetime risk of gastrointestinal cancers as an additional role of MUTYH, it appears to co...

ea0099ep441 | Thyroid | ECE2024

Thyroid function in patients with MUTYH syndrome

de Carlos Joaquin , Zabalza Lucia , Irigaray Ana , Rosario Aznarez Maria , Oquinena Susana , Pineda Arribas Javier , Anda Apinariz Emma

Introduction: MUTYH (MutY homolog Escherichia coli, homolog of MYH, hMYH) is a repair enzyme with a crucial role in the correction of DNA errors, being considered a protective factor of the cell. MUTYH mutations have been linked to MUTYH-associated polyposis syndrome (MAP), an autosomal recessive disorder characterized by multiple colorectal adenomas. Patients with MAP show a much higher lifetime risk of gastrointestinal cancers as an additional role of MUTYH, it appears to co...